undefined undefined
NaN.000
NaN.00%
Corbus Pharmaceuticals press release (NASDAQ:CRBP): Q1 EPS of -$0.83 beats by $0.26. The $116 million of additional capital extends the Company’s cash runway through Q1, 2027. More on Corbus Pharmaceu...
今天 01:13
Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(0.83) per share which beat the analyst consensus estimate of $(1.52) by 45.39 percent. This is a 80.42 percent increase over losses of $(4.24) per share
05-07 20:10
Corbus Pharmaceuticals (CRBP) has shared an update. Corbus Pharmaceuticals Hold...
04-11 05:13
GAINERS: MedMen Enterprises (OTC:MMNFF) shares closed up 900.00% at $1e-05 Aus...
03-13 05:30
Corbus Pharmaceuticals (NASDAQ:CRBP) reported its Q4 earnings results on Tuesda...
03-13 05:05
MNMD隔夜大涨幅51.5%,治疗广泛性焦虑症疗法获FDA审批;OSPN隔夜涨23.1%,四季报亮眼,销售额实现了同比显著增长>>
03-08 19:05
Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades.
01-31 21:31
CRBP隔夜大涨逾35%,获股东增持28.26万股普通股股份;Kura肿瘤学收涨12.1%,公司对白血病联合疗法的研究早期数据积极>>
01-31 19:15
Point72 Capital Advisors, Inc. Discloses 8.8% Passive Stake In Corbus Pharmaceu...
01-30 05:46